Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02GJI
|
|||
| Former ID |
DNC007420
|
|||
| Drug Name |
3-methoxy-N-(1,3,4-thiadiazol-2-yl)benzamide
|
|||
| Synonyms |
3-methoxy-N-(1,3,4-thiadiazol-2-yl)benzamide; ASN 03033124; AC1N2XQD; Oprea1_831715; CHEMBL388817; MolPort-000-015-090; HMS1702F08; ZINC4167694; STK237517; AKOS000648965; MCULE-6144605851; ST064843; 3-Methoxy-N-[1,3,4]thiadiazol-2-yl-benzamide; 3-methoxy-N~1~-(1,3,4-thiadiazol-2-yl)benzamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H9N3O2S
|
|||
| Canonical SMILES |
COC1=CC=CC(=C1)C(=O)NC2=NN=CS2
|
|||
| InChI |
1S/C10H9N3O2S/c1-15-8-4-2-3-7(5-8)9(14)12-10-13-11-6-16-10/h2-6H,1H3,(H,12,13,14)
|
|||
| InChIKey |
UMVWXZHHIZNLAO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | LOX-5 messenger RNA (ALOX5 mRNA) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Arachidonic acid metabolism | |||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.